Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             109 results found
no title author magazine year volume issue page(s) type
1 Author Index 2008
18 S1 p. s95-s98
nvt p.
article
2 Keyword Index 2008
18 S1 p. s99-s100
nvt p.
article
3 P.2.10 Aberrant cytokine response to stress in BALB/c mice after lipopolysaccharide (LPS) challenge: relevance of tryptophan hydroxylase 2 Browne, C.A.
2008
18 S1 p. s44-s45
nvt p.
article
4 P.1.21 Aberrant hippocampal expression of immune signalling-related genes in the rodent models of schizophrenia Lukasz, B.
2008
18 S1 p. s18-s19
nvt p.
article
5 P.1.29 Adolescent cannabinoid exposure induces sex dependent alterations in adulthood: behavioral and biochemical evidences Realini, N.
2008
18 S1 p. s25-
1 p.
article
6 P.2.28 β-adrenoceptor mediated inhibition of long-term alcohol-related memory reconsolidation Wouda, J.A.
2008
18 S1 p. s59-
1 p.
article
7 P.2.09 Alterations in affective startle modulation: indicative of anhedonia? Bijlsma, E.Y.
2008
18 S1 p. s44-
1 p.
article
8 P.1.16 A putative mechanism for interleukin-1- associated nociception via astrocytic glutamate transporters modulation Ziv, N.
2008
18 S1 p. s14-s15
nvt p.
article
9 P.2.12 A role for the opioid system in endocannabinoid-mediated fearconditioned analgesia in rats Butler, R.K.
2008
18 S1 p. s46-s47
nvt p.
article
10 P.1.15 Association of dystrobrevin binding protein 1 gene (DTNBP1) in a bipolar case-control study (BACCS) Gaysina, D.
2008
18 S1 p. s13-s14
nvt p.
article
11 P.3.01 Association of P2RX7 polymorphism with depression in diabetic patients with poor glycemic control Rahman, O. Abdul
2008
18 S1 p. s63-
1 p.
article
12 P.2.08 Attention in adolescents recovered from major depression Wilkinson, P.
2008
18 S1 p. s43-s44
nvt p.
article
13 P.2.15 Behavioural changes in NPY-Y2 and 5HT-1a receptor deficient mice in an automated home cage task for avoidance behaviour de Mooij-van Malsen, J.G.
2008
18 S1 p. s48-s49
nvt p.
article
14 P.2.05 Behavioural responses to morphine in mutants with progressive ablation of D1 receptor-expressing cells Babovic, D.
2008
18 S1 p. s40-s41
nvt p.
article
15 P.1.33 Blockage of the vasopressin V1b receptor prevents the chronic restraint-induced sensitization of the ACTH response to acute noise Spiga, F.
2008
18 S1 p. s28-
1 p.
article
16 P.4.01 Butyrylcholinestherase K variant and apolipoprotein E (APOE) state in subcortical vascular dementia and Alzheimer's disease Álmos, P.
2008
18 S1 p. s85-s86
nvt p.
article
17 P.1.36 Caffeine exacerbates MDMA “Ecstasy”-induced hyperthermia: a role for dopamine D1 receptors Vanattou-Saifoudine, N.
2008
18 S1 p. s30-s31
nvt p.
article
18 P.2.25 Cannabidiol (CBD) ameliorates cognitive impairments associated with a model of chronic liver disease in mice Magen, I.
2008
18 S1 p. s57-
1 p.
article
19 P.4.08 Changes of the phosphorylated form of tau and related signal transduction in young APPswe transgenic mice Mustafiz, T.
2008
18 S1 p. s91-
1 p.
article
20 P.3.16 Characterisation of response to antidepressants in a pharmacogenetic trial Uher, R.
2008
18 S1 p. s75-s76
nvt p.
article
21 P.3.18 Cognitive test scores are lower in adolescent cigarette smokers compared to non-smokers: a population-based study Werbeloff, N.
2008
18 S1 p. s77-s78
nvt p.
article
22 P.2.20 Could nicotine potentiate the beneficial effects of levodopa in the 6-OHDA rat model? A behavioural study Guilloux, J.P.
2008
18 S1 p. s52-s53
nvt p.
article
23 P.3.05 Current and former ecstasy users report different sleep to matched controls: a web based questionnaire study Carhart-Harris, R.
2008
18 S1 p. s66-s67
nvt p.
article
24 P.3.20 Delay of left hemisphere in processing information in schizophrenia? Baiano, M.
2008
18 S1 p. s79-
1 p.
article
25 P.3.21 Delta-9-tetrahydrocannabinol modulates activity in parahippocampal cortex and ventral striatum during memory processing Bhattacharyya, S.
2008
18 S1 p. s80-
1 p.
article
26 P.2.02 Differential sensitivity to dopaminergic manipulations following ovariectomy: an animal model of menopausal psychosis Arad, M.
2008
18 S1 p. s38-s39
nvt p.
article
27 P.3.17 Do patients benefit from practice? An fMRI study in first episode schizophrenia van Veelen, N.
2008
18 S1 p. s76-s77
nvt p.
article
28 P.2.14 Dysfunctional and therapeutic effects of nitric oxide inhibition in a neurodevelopmental model of negative symptoms De Levie, A.
2008
18 S1 p. s48-
1 p.
article
29 P.1.23 Effects of acetylcholine esterase inhibitors on amphetamine-induced dopamine release in the nucleus accumbens Malmlöf, T.
2008
18 S1 p. s20-
1 p.
article
30 P.3.19 Effects of acute alcohol consumption on the processing of perceptual cues of emotional expression Attwood, A.S.
2008
18 S1 p. s78-s79
nvt p.
article
31 P.3.08 Effects of methylphenidate on 18-F fallypride binding in patients with ADHD and healthy controls del Campo, N.
2008
18 S1 p. s69-
1 p.
article
32 P.1.04 Effects of repeated treatment of phencyclidine in cognition, emotional activity and gene expression in C57BL/6J mice Beraki, S.
2008
18 S1 p. s5-
1 p.
article
33 P.2.18 Effects of serotonin1B (5-HT1B) receptor ligands in cocaine priming, discrete cue or food-induced relapses in rats Golda, A.
2008
18 S1 p. s51-s52
nvt p.
article
34 P.1.02 Effects of stress and antidepressants on glutamate release and presynaptic molecular mechanisms Barbiero, V.
2008
18 S1 p. s3-s4
nvt p.
article
35 P.3.07 Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis Cruz, N.
2008
18 S1 p. s68-s69
nvt p.
article
36 P.2.16 Environmental stimulation reduces the rewarding effects of heroin El Rawas, R.
2008
18 S1 p. s49-s50
nvt p.
article
37 P.1.14 Epigenetic down-regulation of atrial natriuretic peptide mRNA expression in females with eating disorders Frieling, H.
2008
18 S1 p. s13-
1 p.
article
38 P.2.17 Estradiol decreases ventral tegmental area self-stimulation threshold and increases cocaine rewarding properties in rats Galankin, T.
2008
18 S1 p. s50-s51
nvt p.
article
39 P.2.21 Exposure to an open-field induces c-Fos in a distributed anxiety-related system projecting to the basolateral amygdala Hale, M.
2008
18 S1 p. s53-s54
nvt p.
article
40 P.1.31 Gender-related differences in synaptic transmission and plasticity in the mouse striatum and nucleus accumbens Schotanus, S.M.
2008
18 S1 p. s26-s27
nvt p.
article
41 P.2.11 Gene function in social and non-social memory Bruining, H.
2008
18 S1 p. s45-s46
nvt p.
article
42 P.3.10 Glutamate and interleukin receptor genes are associated with antidepressant treatment emergent suicidal ideation Menke, A.
2008
18 S1 p. s70-s71
nvt p.
article
43 P.2.24 Glutamate and the reinforcing effects of nicotine Liechti, M.
2008
18 S1 p. s56-
1 p.
article
44 P.1.35 Hippocampal expression of BDNF is involved in the behavioral effects of the β3 adrenoceptor agonist, SR58611A Tamburella, A.
2008
18 S1 p. s29-s30
nvt p.
article
45 P.2.29 Hyperactivity and response to amphetamine in SynGAP heterozygous knockout mice Muhia, M.
2008
18 S1 p. s60-
1 p.
article
46 P.3.11 Hypothalamic serotonin-1A receptor binding correlates with plasma levels of dehydroepiandrosterone and cortisol Moser, U.
2008
18 S1 p. s71-s72
nvt p.
article
47 P.1.32 Imidazoline2 (I2) binding site ligands increase Fos-like immunoreactivity in the naive and restraint-stressed rat brain Smith, K.
2008
18 S1 p. s27-s28
nvt p.
article
48 P.2.22 Impact of behavioural sensitization to methamphetamine on i.v. selfadminitration of the drug in male and female rats Kucerova, J.
2008
18 S1 p. s54-s55
nvt p.
article
49 P.1.06 Impaired mitochondrial respiration due to dopamine inhibition of complex I activity: implication to schizophrenia Lavie, H. Brenner
2008
18 S1 p. s6-s7
nvt p.
article
50 P.1.30 Inflammation down-regulates β2-adrenoceptor expression on primary glia: reversal by the glucocorticoid dexamethasone Ryan, K.M.
2008
18 S1 p. s25-s26
nvt p.
article
51 P.1.05 Involvement of DARPP-32, FosB, and dynorphin in voluntary wheel running Borgkvist, A.
2008
18 S1 p. s5-s6
nvt p.
article
52 P.2.03 Lack of CB1 receptor alters serotonin system: an electrophysiological and in vivo microdialysis study Aso, E.
2008
18 S1 p. s39-
1 p.
article
53 P.3.24 Lower 5-HT1A receptor binding in patients with borderline personality disorder: a PET study using [11C]WAY100635 Jovanovic, H.
2008
18 S1 p. s82-s83
nvt p.
article
54 P.2.06 MDMA modifies active avoidance learning and recall in mice Trigo-Diaz, J.
2008
18 S1 p. s41-s42
nvt p.
article
55 P.1.20 Mechanisms of the antidepressant action of triiodothyronine: functional, behavioral and gene expression studies Lifschytz, T.
2008
18 S1 p. s17-s18
nvt p.
article
56 P.4.04 Mechanistic studies of amyloid processes in Alzheimer's disease—consequences of different forms of beta-amyloid Hedberg, M.M.
2008
18 S1 p. s88-
1 p.
article
57 P.4.09 Mitochondrial dysfunction as an emerging preclinical concept of Alzheimer's disease Rhein, V.
2008
18 S1 p. s92-
1 p.
article
58 P.1.28 Modulation of intracellular signaling patwhays by acute swim stress in rat hippocampus Pasini, M.
2008
18 S1 p. s24-
1 p.
article
59 P.1.19 Modulators of inhibitory synaptic transmission in mouse somatosensory cortex Kruglikov, I.
2008
18 S1 p. s17-
1 p.
article
60 P.1.03 Molecular effects of subchronic and chronic treatment with escitalopram in the rat central nervous system Benatti, C.
2008
18 S1 p. s4-s5
nvt p.
article
61 P.3.23 Molecular imaging of early visual cortex by combining pet and fMRI Gerstl, F.
2008
18 S1 p. s81-s82
nvt p.
article
62 P.3.02 Molecular imaging of the 5-HT1A receptor and 5-HTT in relation to cognitive functions in man Borg, J.
2008
18 S1 p. s64-
1 p.
article
63 P.1.26 Morphological analyses of neurons in serotonin transporter (5-Htt) knockout mice Nietzer, S.
2008
18 S1 p. s22-s23
nvt p.
article
64 P.2.07 Muscarinic transmission in the entorhinal cortex mediates inattention to irrelevant stimuli: relevance to schizophrenia Barak, S.
2008
18 S1 p. s42-s43
nvt p.
article
65 P.1.11 Neurobiology of improved stress-coping in voluntarily exercising rats Collins, A.
2008
18 S1 p. s10-s11
nvt p.
article
66 P.3.04 Neurocognitive functioning in patients with different type of abuse Bushara, N.
2008
18 S1 p. s65-s66
nvt p.
article
67 P.2.23 Neuropsychopharmacological specificity in drug addiction: no cross-escalation between cocaine and heroin use Lenoir, M.
2008
18 S1 p. s55-s56
nvt p.
article
68 P.4.10 Nicotinic acetylcholine receptor (nAChR) desensitization and its relevance to physiological and behavioral functions Shacar, M.
2008
18 S1 p. s92-s93
nvt p.
article
69 P.3.15 Peg-interferon alpha and ribavirin therapy may induce working memory disturbances in chronic hepatitis C patients Pawelczyk, A.
2008
18 S1 p. s74-s75
nvt p.
article
70 P.4.07 Peroxisome proliferator-activated receptors (PPARs): new target for attention and memory function Mazzola, C.
2008
18 S1 p. s90-s91
nvt p.
article
71 P.1.34 Progesterone and estradiol plasma levels modulate serotonin-1A binding in the human brain Spindelegger, C.
2008
18 S1 p. s28-s29
nvt p.
article
72 P.1.37 Proline affects brain function in 22q11DS children with the low-activity COMT158 allele Vorstman, J.A.S.
2008
18 S1 p. s31-s32
nvt p.
article
73 P.1.09 Prolonged monoamine oxidase inhibition alters the firing activity of dopamine neurons in the ventral tegmental area Chenu, F.
2008
18 S1 p. s9-
1 p.
article
74 P.1.13 Pulsatile glucocorticoid secretion: does it matter? Wiles, C.C.
2008
18 S1 p. s12-
1 p.
article
75 P.4.03 Rational design of a drug for Alzheimer's disease with cholinesterase inhibitory and neuroprotective activity Groner, E.
2008
18 S1 p. s87-
1 p.
article
76 P.1.08 Reduction in neuroactive steroids levels, induced by neonatal exposure to estrogen, changes GABAA receptor plasticity Calza, A.
2008
18 S1 p. s8-
1 p.
article
77 P.4.06 Regional sensitivity or resistance to neuroinflammation: in vivo and in vitro studies Zaltsman, S. Liraz
2008
18 S1 p. s89-s90
nvt p.
article
78 P.1.07 Regulation of brain-derived neurotrophic factor expression by cocaine in rat brain and its modulation by stress Caffino, L.
2008
18 S1 p. s7-s8
nvt p.
article
79 P.2.19 Role of CB1 receptor system in a pharmacological model of schizophrenia Guidali, C.
2008
18 S1 p. s52-
1 p.
article
80 P.2.27 Role of neurosteroids in the modulation of neuropeptide Y Y1 receptor neurotransmission during ethanol and ghb withdrawal Mele, P.
2008
18 S1 p. s58-s59
nvt p.
article
81 P.3.22 Serotonin1A receptor distribution may predict neural reactivity as shown by multimodal neuroimaging with fMRI and PET Fink, M.
2008
18 S1 p. s80-s81
nvt p.
article
82 P.1.24 Serotonin transporter gene and adverse life events in adult ADHD Mandelli, L.
2008
18 S1 p. s21-
1 p.
article
83 P.3.03 Seven days of citalopram reduces sensitivity to negative appraisal in a probabilistic learning task Browning, M.
2008
18 S1 p. s64-s65
nvt p.
article
84 P.2.26 Significance of a genetically de.ned GABAA-receptor de.cit on breathing behaviour: relevance to respiratory panic Masneuf, S.
2008
18 S1 p. s57-s58
nvt p.
article
85 P.3.14 Specific antipsychotic medications—a treatment for aggressive behaviour in schizophrenia? Patel, K.
2008
18 S1 p. s73-s74
nvt p.
article
86 P.1.38 Splice variants of hippocampal NR1 subunit of NMDA receptor in schizophrenia Vrajova, M.
2008
18 S1 p. s32-s33
nvt p.
article
87 P.1.25 Striatal synaptic and cortical nuclear orphan G protein-coupled receptor GPR88, a promising target for psychiatric and movement disorders Massart, R.
2008
18 S1 p. s21-s22
nvt p.
article
88 P.1.22 Synaptoproteomic analysis of a rat model of depression with gene-environment interaction Mallei, A.
2008
18 S1 p. s19-s20
nvt p.
article
89 P.4.05 The attenuating effect of memantine on doxorubicin-induced apoptosis of primary neurons and neuroblastoma SH-SY5Y cells Jantas, D.
2008
18 S1 p. s88-s89
nvt p.
article
90 P.1.10 The depression case control study in the whole genome association era: results and implications for the future Cohen, S.
2008
18 S1 p. s9-s10
nvt p.
article
91 P.1.27 The effect of antidepressant drugs on the HPA axis activity, glucocorticoid receptor and FK506 binding protein 51 (FKBP-51) concentration in animal model of depression Otczyk, M.
2008
18 S1 p. s23-s24
nvt p.
article
92 P.2.01 The effect of fatty acid amide hydrolase inhibitors in cocaine or food self administration Adamczyk, P.
2008
18 S1 p. s37-s38
nvt p.
article
93 P.1.01 The effect of influenza A/WSN/33 virus infections on the kynurenine pathway Asp, L.
2008
18 S1 p. s2-s3
nvt p.
article
94 P.4.11 The effect of rivastigmine on learning and memory processes after bilateral nucleus basalis of Meynert lesions in rats Mellios, G.
2008
18 S1 p. s93-s94
nvt p.
article
95 P.2.04 The effect of two behavioral tests on the corticosterone level in plasma of mice lacking the noradrenaline transporter Solich, J.
2008
18 S1 p. s40-
1 p.
article
96 P.1.18 The genetic basis of individual vulnerability to chronic stress: role of AMPA receptors Schmidt, M.V.
2008
18 S1 p. s16-
1 p.
article
97 P.1.12 The neuroprotective effects of the group III metabotropic glutamate receptor agonist ACPT-1 in vitro and in vivo Domin, H.
2008
18 S1 p. s11-s12
nvt p.
article
98 P.3.13 The niacin skin flush test in schizophrenia-a combined approach using laser doppler flowmetry and a visual rating scale Must, A.
2008
18 S1 p. s73-
1 p.
article
99 P.3.09 The predictive value of neurocognitive decision-making for heavy alcohol use in a longitudinal, prospective study Goudriaan, A.
2008
18 S1 p. s69-s70
nvt p.
article
100 P.1.17 Topographical and temporal distribution of Homer1a expression is correlated to antipsychotics dopaminergic profile Iasevoli, F.
2008
18 S1 p. s15-s16
nvt p.
article
101 P.4.02 Transforming growth factor-β1 (TGF-β1) signaling as a new pharmacological target against Aβ-induced neurodegeneration Caraci, F.
2008
18 S1 p. s86-s87
nvt p.
article
102 P.2.13 Translational research into sexual disorders: pharmacology and behavior Chan, J.
2008
18 S1 p. s47-s48
nvt p.
article
103 P.2.30 Triple dissociation of serotonergic in.uence on motivational behaviour under positive, negative and neutral mood Robinson, O.J.
2008
18 S1 p. s60-s61
nvt p.
article
104 P.3.06 Tryptophan degradation in psychosis: simultaneous measurement of tryptophan and kynurenine pathway metabolites by HPLC Clarke, G.
2008
18 S1 p. s67-s68
nvt p.
article
105 P.3.12 Using pharmacological fMRI to examine the effect of an SSRI on the neural circuitry underpinning threat processing Murphy, S.E.
2008
18 S1 p. s72-s73
nvt p.
article
106 S.1.01 Neuropeptidergic mechanisms and mental disease Hökfelt, T.
2008
18 S1 p. s1-s2
nvt p.
article
107 S.2.02 Novel approaches in behavioural genomics Kas, M.J.H.
2008
18 S1 p. s36-s37
nvt p.
article
108 S.2.01 Psychopharmacological models focusing on stimulus bound behaviour Markou, A.
2008
18 S1 p. s35-s36
nvt p.
article
109 S.4.02 What are the drug targets in dementia: cognition, behaviour, …? Robert, P.
2008
18 S1 p. s85-
1 p.
article
                             109 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands